Methods: 738 laboratories were included. Questionnaires involved general information and data of related indicators of TAT during 1 week were provided to participating laboratories. Nine quality indicators were covered, which were medians, 90th and outlier rates of pre-examination, examination, and post-examination TAT. The 25th percentile, median, and 75th percentile of TATs were calculated as optimum, desirable, and minimum quality specifications. Percentages and sigma values were used to describe the outlier rates. Mann-Whitney and Kruskal-Wallis tests were used to identify the potential impacts of TAT.
| INTRODUCTION
Laboratories tend to focus more on the technical and quality for the accuracy and reliability of test results. However, clinicians and patients value the timeliness of results reporting, and they might agree to sacrifice some analytical quality in order to obtain more rapid results. 1 For that reason, many clinicians prefer to employ point of care (POC) testing. Turnaround time (TAT) is one of the most vital quality indicators (QIs) and always considered as a key indicator of laboratory services. 2 Delayed TAT will immediately lead to complaints from patients and clinicians.
TAT is defined as "elapsed time between two specified points through pre-examination, examination, and post-examination processes" according to ISO 15189:2012, 3 including time of clinician requisition, sample collection, sample transportation, sample analysis, etc. It also stated that "laboratories should determine the TAT for each analytes, and audit whether laboratories can meet the goal TAT regularly." Clinical Laboratory Improvement Amendments (CLIA'88),
College of American Pathologists (CAP) and International Federation
of Clinical Chemistry (IFCC) have set requirements for TAT monitoring in clinical laboratories, as well. 4, 5 Chinese National Center for Clinical Laboratories (NCCL) has conducted a national investigation on intra-laboratory TAT in 2011, which demonstrated the unsatisfied performance of intra-TAT. 6 In order to further study the baseline of TAT across the total testing spectrum, and help clinical laboratories to set their appropriate goal TAT, an overall investigation on TAT nationwide were conducted. This survey involved nine quality indicators, which were medians, 90th and outlier rates of pre-examination, examination, and post-examination TAT. Pre-examination TAT was defined as the time taken from sample collection to reception, examination TAT was the time taken from reception to results reporting, and postexamination TAT was the time from results reporting to results reception by clinicians.
| MATERIALS AND METHODS

| Study design
In total 1589 clinical laboratories in China, which had participated in clinical biochemistry of external quality assessment (EQA) programs organized by the NCCL were included in this survey in July 2015.
Private laboratories, Centers for Clinical Laboratories, and independent commercial laboratories were excluded for their various TATs.
Questionnaires that covered two parts were sent to participating laboratories. The first part was about the general conditions of participating laboratories: 1) general information on clinical laboratories and hospitals; 2) investigation on TAT monitoring; 3) elements that may influence TAT. Kolmogorov-Smirnov (K-S) test indicated the distributions of TAT data were non-Gaussian with a positive skew, indicated that median and tail size are the preferred measures. 7 Therefore, the second part was aimed to collect the data of TATs during 1 week according 9 QIs: median of pre-examination TAT, median of examination TAT, median of post-examination, 90th of pre-examination TAT, 90th of examination TAT, 90th of post-examination TAT, outlier rates of pre-examination TAT, outlier rates of examination TAT, and outlier rates of post-examination TAT. Eight tests were involved in the questionnaire of routine biochemistry analytes, including potassium, glucose, total protein, alanine transaminase (ALT), magnesium, triglyceride, creatine kinase-MB (CK-MB), and troponin (cTn) respectively.
Five tests were provided in the questionnaire of stat biochemistry analytes, including potassium, glucose, CK-MB, cTn, and amylase.
Related indicators of TATs were separately analyzed in accordance with routine biochemistry analytes and stat ones. Stat tests were tests ordered when the results urgently needed, particularly for patients with severe diseases, patients from emergency department, and inpatients whose condition change suddenly.
| Data collection
All laboratories were informed of the EQA program of TAT investigation by both paper and message notification and asked to submit the questionnaire within 1 month after receiving it. Electronic notice and guidelines for data filling in can be downloaded from an online EQA platform developed by NCCL (www.clinet.com.cn). 8 The data of nine QIs of TATs in laboratories can be collected via either laboratory information system (LIS) or manually. Three methods were given for laboratories in submitting their results likewise, online EQA platform, E-mail and regular mails respectively. Besides, this EQA program of TAT investigation is free of charge and without punishment.
| Statistics analysis
All the collected data were calculated and analyzed through the special statistical software designed by NCCL and developed by the The 25th percentile (25th), median, and the 75th percentile (75th) of median TATs were calculated as optimum, desirable and minimum quality specifications. TAT, turnaround time; ALT, alanine aminotransferase; CK-MB, creatine kinase-MB; cTn, troponin. 
| RESULTS
| Nine QIs of TATs for routine and stat tests
As shown in Table 2 , the medians of pre-examination, examination, and post-examination TATs of routine and stat biochemistry tests varied among different analytes. For routine biochemistry analyte, the median TATs of cTn and CK-MB were lower than that of other analytes, while magnesium and triglyceride were slight higher. The medians of postexamination TATs in most laboratories were 0min. M-W test showed that significant differences existed between median TATs of routine and stat analytes in three time intervals (P<.05). As shown in Table 3 , the 90th of pre-examination, examination, and post-examination TATs of routine and stat biochemistry tests were diverse from different biochemistry analytes. The P value of M-W test between 90th TATs of routine and stat analytes in three time intervals was less than .05.
Outlier rates were considered as the number of specimens of each analyte exceeding the goal TAT set by a laboratory dividing by the total number of specimens in this laboratory. The goal TATs of biochemistry analytes set by laboratories are described in Table 4 . above, which presented as both % and σ (Table 5) .Among these analytes, outlier rates of CK-MB and cTn were lower and achieved quality more than 4σ, while potassium had higher outlier rates. M-W test suggested there were no significant differences between outlier rates of routine and stat tests for different analytes (P value >.05 for each analyte).
| Potential impact factor analysis
K-S test indicated that the distribution of each group was abnormal (P<.05). Percentage (%) of outlier rate was considered as the number of specimens exceeding the goal TAT set by a laboratory dividing by the total number of specimens in this laboratory. σ scales for the outlier rates can be calculated according to the percentages. 6σ represents "world class quality", which is defined as 3.4 defects per million (a). TAT, turnaround time; ALT, alanine aminotransferase; CK-MB, creatine kinase-MB; cTn, troponin.
| DISCUSSION
The return rate of this survey was 46.44%, which was lower compared to the national appropriateness of clinical reporting survey in 2013. 12 However, it was obvious higher than the national TAT survey in 2011, 6 stating the growing attention of laboratories on importance of TAT monitoring. A total of 738 laboratories participated in the EQA program of TAT, with more tertiary, which signified relatively mature laboratory quality management system in China. It was our object likewise to implement the "quality indicators" in these hospitals first and then promote to nationwide. Comparing with the survey in 2011, 6 this survey contained pre-examination and post-examination phases other than intra-laboratory TAT. Meanwhile, the 90th and outlier rates were added to reflect the tail data.
Percentages of laboratories who monitored examination TATs regularly were much higher than that of pre-examination and post-examination TATs (80% vs 50%). Laboratories tended to monitor TATs they could control, the factors in pre-examination and post-examination phases were also the main causes of delayed TAT, however. 13, 14 Consequently, TATs across the total testing spectrum should be monitored so as to shorten TAT radically and improve clin- A Q-Probes study launched by CAP demonstrated that clinicians expected of a shortened TAT than laboratories could provide. 15 Hence, in addition to referring to research at home and abroad, goal TAT setting is a more personalized practice, and laboratories should consider its own circumstance and communication with the clinic. Compared with outlier rates of examination and post-examination TATs, outlier rates of pre-examination TATs were relatively high, which reflected the insufficient impetus for pre-examination TAT monitoring. More attention should be taken to strengthen the supervision on pre-examination TAT and adopt measures to improve gradually.
In general, tertiary hospitals and accreditation laboratories often had better capacities than non-tertiary and non-accredited ones.
Surprisingly, the medians and 90th of pre-examination and examination TATs of tertiary hospitals were higher than that of non-tertiary hospitals, TATs of ISO 15189 or CAP accreditation laboratories were apparently longer than that of non-accreditation laboratories. The conflicting situation may result from the great amount of patients and samples in large-scale hospitals. The workload of transportation and laboratory staff was extremely heavy, and it was required to line up and wait for batch processing in the sample collection, transportation, testing, results check and reporting. In contrast, a lot of waiting time could be eliminated or reduced in small-size hospitals due to the fewer patients, and shorten TATs were deserved.
Multiple studies showed that mechanical pipeline transportation of all types often possessed high uptake rate and relatively low TATs. 16, 17 There were no statistically significant among medians and 90th of pre- Reasons for delayed TATs were also investigated. Some worthy advices were provided for laboratories to implement improvement, for instance, process optimization of sample collection and transportation in pre-examination phase, new instrument purchase in examination phase, valid backup plan for LIS breakdown to send report timely in post-examination phase. Insufficient personnel and large amount of samples were common causes of delayed TAT across the total testing spectrum. In summary, laboratories should monitor the TAT across the total testing spectrum due to the different ways for ameliorating in different phases, seek the reasons for delayed TAT pointedly and ensure timely testing.
There were some flaws exist in our survey. Firstly, TAT was defined as time taken from sample collection to results reception by clinicians, regardless the time from sample requisition to collection and time from results reception by clinicians to take actions. That was because the difficulty of obtaining these periods of time. Secondly, tertiary hospitals were the main participating laboratories in this survey with high patient-volume, which could not be on behalf of the national level.
Finally, it was only a cross-sectional survey, merely involving a 1-week time window, so the results just reflects a one-time situation. Further investigation is needed to show the long-time performance of laboratory TAT in China.
| CONCLUSIONS
In spite of the remarkable progresses of TATs in China, there was also great room to improve. Medians and 90th of TATs across the total testing spectrum of some laboratories were extremely large.
Therefore, more effort should be made by laboratories to strengthen information system development. In this way, reasons of delayed TATs can be identified through internal longitudinal monitoring and external horizontal comparison, and we can finally achieve continuous improvement for quality of laboratories services.
